Accolate (zafirlukast), a new ORAL drug for asthma

December 1997

Zeneca is now marketing Accolate (zafirlukast), a new ORAL drug for asthma. It's taken chronically to control asthma symptoms.

Accolate is the first drug in a new class...called leukotriene receptor antagonists.

Leukotrienes are released from mast cells after exposure to allergens. They provoke inflammation and bronchoconstriction.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

ginkgo for Alzheimer's
Accolate (zafirlukast), a new ORAL drug for asthma
restricting sales of terfenadine (Seldane) and astemizole (Hismanal)
Cardiology Pravachol (pravastatin) to prevent a FIRST heart attack
Cardiology new guidelines for using ASA for heart attacks
Hypertension new recommendations for treating hypertension
higher intakes of calcium and vitamin D are being proposed
most older people don't get enough vitamin D
Infectious Diseases Neupogen (filgrastim, G-CSF) to treat diabetic foot infections
Infectious Diseases Two protease inhibitors
Infectious Diseases Fortovase, a "stronger" version of Invirase
Two forms of 5-aminosalicylic acid
major breakthrough is on the horizon for Crohn's disease
figuring out what genes make people susceptible to Crohn's and colitis
two new Oral drugs for impotence
Women's Health Natural hormone therapy
Women's Health get info from the Motherrisk Program on - line
Antiemetics new antiemetic, Anzemet (dolasetron)
Practice tell patients who have taken Redux, Pondimin, or Ponderal to see their physician for a heart exam